Why Clinuvel, De Grey, and Advance NanoTek are soaring higher today

On a day that's seen another sea of red across the S&P/ASX 200 Index (INDEXASX:XJO), here are 3 ASX shares that are shining lights today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On a day that's seen another sea of red across the S&P/ASX 200 Index (INDEXASX: XJO), here are 3 ASX shares that are shining lights today.

Advance Nanotek Ltd (ASX: ANO)

The Advance Nanotek share price is trading 4.2% higher at the time of writing following an ASX announcement containing several updates yesterday afternoon.

Yesterday, the company reported it has started investigations into a possible capital reduction which may go ahead before the end of FY20. Additionally, in a profitability update, the company noted it recorded just over $1 million profit before tax for the month of February 2020. Along with this, the company added that its operations remain debt-free, and it has in excess of $1.9 million in the bank.

On top of these updates, the company also announced the signing of a new distribution agreement. Deveraux Specialties is to be Advance NanoTek's non-exclusive distributor for Canada. Advance Nanotek is aiming to grow its Canadian operations over the next year, as it has recently done in the US.

In addition, the company provided an update with regards to the potential impact of the coronavirus. Despite receiving 'concerning' feedback from its US distributor, Advance NanoTek believes its product will continue to experience demand.

Clinuvel Pharmaceuticals Limited (ASX: CUV)

The Clinuvel share price has surged higher today by 5.1% at the time of writing. Today's increase appears to be linked to an ASX release earlier in the week.

On Tuesday, Clinuvel announced it had secured a meeting with the US Food and Drug Administration (FDA) to progress the use of its drug, SCENESSE, for the treatment of vitiligo. The disease is a skin disorder characterised by the appearance of white to off-white skin patches in different parts of the body due to the loss of melanin production.

Pending ongoing safety and efficacy of its vitiligo program, Clinuvel will seek to file a supplemental New Drug Application for SCENESSE. The Clinuvel share price rocketed as much as 25% on the day of the announcement. After slightly dipping yesterday, this momentum appears to be pushing shares higher today.

De Grey Mining Limited (ASX: DEG)

The De Grey Mining share price is up by 3.04% today at the time of writing. Today's rise comes on the back of a massive 24.3% gain yesterday after the company announced results from drilling programs at the newly discovered Hemi Prospect. In early trade yesterday, De Grey Mining shares climbed as much as 44.44% higher.

According to yesterday's release, the company's recent drilling has revealed wide, continuous, and high-quality grade gold mineralisation. De Grey Mining believes this confirms a large-scale gold system at Hemi.

Additionally, the company believes that the significant sulphide zones beneath the high-grade gold zones are very encouraging, and the large sulphide zones have the potential to significantly increase Hemi's scale.

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Advance NanoTek Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »